InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by O'Brien James Michael, Chief Financial Officer. Insider active across 1 company, notably Cognition Therapeutics INC. In total, 2 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €103k. History available since 13 October 2021. The latest transaction was filed on 13 October 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
5,000 shares@ US$12.000.043% mcap50.0% of flowCommon StockSEC:0001104659-21-126361:0
Ideal exit: 10 Jul 2022 (T+270)
5,000 shares@ US$12.000.043% mcap100.0% of flowCommon StockSEC:0001104659-21-126361
Ideal exit: 10 Jul 2022 (T+270)
2 of 2 declarations
About O'Brien James Michael
James Michael O'Brien is the Chief Financial Officer at COGNITION THERAPEUTICS INC. He oversees the financial operations of the company, including risk management and strategic planning. James plays a key role in financial strategy and the company's growth.
